In this study, we investigated the effect of aqueous extract of Prunella vulgaris (Labiatae; PVAE) on the mast cell–mediated allergy model. We found that PVAE (0.001–0.1 g/kg) dose dependently inhibited compound 48/80–induced systemic anaphylaxis and serum histamine release in mice. PVAE decreased the IgE-mediated local allergic reaction, passive cutaneous anaphylaxis. In addition, PVAE attenuated phorbol 12-myristate 13-acetate (PMA) and calcium ionophore A23187-stimulated TNF-α, IL-6, and IL-8 secretion in human mast cells. The inhibitory effect of PVAE on proinflammatory cytokines was nuclear factor-κB (NF-κB) dependent. PVAE suppressed PMA and A23187-induced NF-κB/DNA binding activity and NF-κB–dependent gene reporter assay. Our findings provide evidence that PVAE inhibits mast cell–derived immediate-type allergic reactions and involvement of proinflammatory cytokines and NF-κB in these effects.
Kimura T, But PPH, Guo JX, Sung CK, Han BH. International Collation of Traditional and Folk Medicine (1). Hackensack, NJ: World Scientific, p141, 1966.
3.
Lee SJ. Korean Folk Medicine. Seoul, Korea: Publishing Center of Seoul National University, pp121–123, 1966.
4.
Lagunoff D, Martin TW, Read G. Agents that release histamine from mast cells. Annu Rev Pharmacol Toxicol23:331–351, 1983.
5.
Ennis M, Pearce FL, Weston PM. Some studies on the release of histamine from mast cells stimulated with polylysine. Br J Pharmacol70:329–334, 1980.
6.
Alfonso A, Cabado AG, Vieytes MR, Botana LM. Functional compartments in rat mast cells for cAMP and calcium on histamine release. Cell Signal12:343–350, 2000.
7.
Beaven MA, Rogers J, Moore JP, Hesketh TR, Smith GA, Metcalfe JC. The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J Biol Chem259:7129–7136, 1984.
8.
Beaven MA, Metzger H. Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol Today14:222–226, 1993.
9.
Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, Howarth PH. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol151:3853–3865, 1993.
10.
Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med170:245–257, 1989.
11.
Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature339:64–67, 1989.
12.
Azzolina A, Bongiovanni A, Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta1643:75–83, 2003.
13.
Shin TY, Kim SH, Suk K, Ha JH, Kim I, Lee MG, Jun CD, Kim SY, Lim JP, Eun JS, Shin HY, Kim HM. Anti-allergic effects of Lycopus lucidus on mast cell-mediated allergy model. Toxicol Appl Pharmacol209:255–262, 2005.
14.
Kim SH, Shin TY. Amomum xanthiodes inhibits mast cell-mediated allergic reactions through the inhibition of histamine release and inflammatory cytokine production. Exp Biol Med (Maywood)230: 681–687, 2005.
15.
Kim SH, Choi CH, Kim SY, Eun JS, Shin TY. Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model. Exp Biol Med (Maywood)230:82–88, 2005.
16.
Kim SH, Jun CD, Suk K, Choi BJ, Lim H, Park S, Lee SH, Shin HY, Kim DK, Shin TY. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci91:123–131, 2006.
17.
Lee DH, Kim SH, Eun JS, Shin TY. Mosla dianthera inhibits mast cell-mediated allergic reactions through the inhibition of histamine release and inflammatory cytokine production. Toxicol Appl Pharmacol216: 479–484, 2006.
18.
Shin HY, Kim SH, Jeong HJ, Kim SY, Shin TY, Um JY, Hong SH, Kim HM. Epigallocatechin-3-gallate inhibits secretion of TNF-alpha, IL-6 and IL-8 through the attenuation of ERK and NF-kappaB in HMC-1 cells. Int Arch Allergy Immunol142:335–344, 2006.
19.
Mousli M, Bronner C, Bockaert J, Rouot B, Landry Y. Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. Immunol Lett25:355–357, 1990.
20.
Mican JA, Arora N, Burd PR, Metcalfe DD. Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J Allergy Clin Immunol90:815–824, 1992.
21.
Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A88:4220–4224, 1991.
22.
Mullarkey MF, Leiferman KM, Peters MS, Caro I, Roux ER, Hanna RK, Rubin AS, Jacobs CA. Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor. J Immunol152:2033–2041, 1994.
23.
Sengupta B, Banerjee A, Sengupta PK. Investigations on the binding and antioxidant properties of the plant flavonoid fisetin in model biomembranes. FEBS Lett570:77–81, 2004.
24.
Collart MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol10:1498–1506, 1990.
25.
Psotova J, Svobodova A, Kolarova H, Walterova D. Photoprotective properties of Prunella vulgaris and rosmarinic acid on human keratinocytes. J Photochem Photobiol B84:167–174, 2006.
26.
Psotova J, Chlopcikova S, Miketova P, Simanek V. Cytoprotectivity of Prunella vulgaris on doxorubicin-treated rat cardiomyocytes. Fitoterapia76:556–561, 2005.
27.
Psotova J, Kolar M, Sousek J, Svagera Z, Vicar J, Ulrichova J. Biological activities of Prunella vulgaris extract. Phytother Res17: 1082–1087, 2003.
28.
Ryu SY, Oak MH, Yoon SK, Cho DI, Yoo GS, Kim TS, Kim KM. Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris. Planta Med66:358–360, 2000.
